Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus

Hongyu Yin, Henrik O. Berdel, David Moore, Franklin Davis, Jun Liu, Mahmood S Mozaffari, Jack C Yu, Babak Baban

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.

Original languageEnglish (US)
Article number578
JournalSpringerPlus
Volume4
Issue number1
DOIs
StatePublished - Dec 1 2015

Fingerprint

Vibration
Type 2 Diabetes Mellitus
Urine
Therapeutics
Interleukin-17
Osmolar Concentration
Hemoglobins
Body Weight
Polydipsia
Glucose
Polyuria
Aptitude
Regulatory T-Lymphocytes
Helper-Inducer T-Lymphocytes
DNA Damage
Compliance
Life Style
Anti-Inflammatory Agents
Obesity
Inflammation

ASJC Scopus subject areas

  • General

Cite this

Whole body vibration therapy : a novel potential treatment for type 2 diabetes mellitus. / Yin, Hongyu; Berdel, Henrik O.; Moore, David; Davis, Franklin; Liu, Jun; Mozaffari, Mahmood S; Yu, Jack C; Baban, Babak.

In: SpringerPlus, Vol. 4, No. 1, 578, 01.12.2015.

Research output: Contribution to journalArticle

Yin, Hongyu ; Berdel, Henrik O. ; Moore, David ; Davis, Franklin ; Liu, Jun ; Mozaffari, Mahmood S ; Yu, Jack C ; Baban, Babak. / Whole body vibration therapy : a novel potential treatment for type 2 diabetes mellitus. In: SpringerPlus. 2015 ; Vol. 4, No. 1.
@article{4d929e289e2c4ae0b1b8a887178ca51c,
title = "Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus",
abstract = "There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.",
author = "Hongyu Yin and Berdel, {Henrik O.} and David Moore and Franklin Davis and Jun Liu and Mozaffari, {Mahmood S} and Yu, {Jack C} and Babak Baban",
year = "2015",
month = "12",
day = "1",
doi = "10.1186/s40064-015-1373-0",
language = "English (US)",
volume = "4",
journal = "SpringerPlus",
issn = "2193-1801",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Whole body vibration therapy

T2 - a novel potential treatment for type 2 diabetes mellitus

AU - Yin, Hongyu

AU - Berdel, Henrik O.

AU - Moore, David

AU - Davis, Franklin

AU - Liu, Jun

AU - Mozaffari, Mahmood S

AU - Yu, Jack C

AU - Baban, Babak

PY - 2015/12/1

Y1 - 2015/12/1

N2 - There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.

AB - There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.

UR - http://www.scopus.com/inward/record.url?scp=84943393089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943393089&partnerID=8YFLogxK

U2 - 10.1186/s40064-015-1373-0

DO - 10.1186/s40064-015-1373-0

M3 - Article

AN - SCOPUS:84943393089

VL - 4

JO - SpringerPlus

JF - SpringerPlus

SN - 2193-1801

IS - 1

M1 - 578

ER -